TransCode Therapeutics, Inc. - Common Stock (RNAZ)

Transcode Therapeutics Inc is a biotechnology company focused on developing innovative RNA-based therapeutics aimed at treating cancer and other serious diseases

The company specializes in harnessing the potential of RNA to create targeted therapies that can address the underlying mechanisms of diseases, particularly in oncology. By leveraging its proprietary technology platforms, Transcode aims to enhance the precision of cancer treatments and improve patient outcomes, while also exploring applications in other therapeutic areas. The company's commitment to advancing RNA therapeutics positions it at the forefront of cutting-edge research in the life sciences field.